To Cite:
Haro
G. New Clinical Implications of Opiate Maintenance Treatments,
Int J High Risk Behav Addict.
2012
; 1(2):88-89.
doi: 10.5812/ijhrba.6532.
1.
Haro G, Martinez-Raga J, Castellano M, Bolinches F, de Vicente P, Valderrama JC. [Heroin prescribing: Is there scientific evidence of its efficacy for the treatment of its dependence?]. Actas Esp Psiquiatr. 2001; 29(5): 343-8[PubMed]
2.
McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993; 269(15): 1953-9[DOI][PubMed]
3.
Zylicz Z. Opioidinduced hypogonadism: the role of androgens in the wellbeing and pain thresholds in men and women with advanced disease. J Adv in Palliative Med. 2009; 8(2): 57-62
4.
Kolar AF, Brown BS, Weddington WW, Ball JC. A treatment crisis: cocaine use by clients in methadone maintenance programs. J Subst Abuse Treat. 1990; 7(2): 101-7[DOI]
5.
Heidari Z, Mahmoudzadeh-Sagheb H, Kohan F. A Quantitative and Qualitative Study of Rat Testis Following Administration of Methadone and Buprenorphine. Int J High Risk Behav Addict. 2012; 1(1): 12-5[DOI]
6.
Benito A, Haro G, Orengo T, Gonzalez M, Fornes T, Mateu C. [Opiate Dependence Type II or antisocial: Cloningers Psychobiological Model and its usefullness in addictions]. Adicciones. 2012; 24(2): 131-8[PubMed]
Readers' Comments